BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4//
BEGIN:VEVENT
UID:20260622T215941EDT-3672LdLovu@132.216.98.100
DTSTAMP:20260623T015941Z
DESCRIPTION:Every year\, billions of dollars are invested by funding agenci
 es in basic and translational research\, yet the path from academic discov
 ery to private investment necessary for the creation of new companies is r
 arely straightforward. In this seminar\, you'll get an inside look at how 
 investors work\, what makes a research idea stand out to venture capitalis
 ts\, and how they evaluate translational value of scientific opportunities
 . By the end of the session\, you’ll have a clearer grasp of the framework
  needed to transition an idea or mechanism discovered in the lab to an inv
 estment phase.\n\nThis event is can be attended in-person at D2R Offices (
 1010 Sherbrooke St. West\, Suite 1800 (18th floor) OR virtually on Zoom.\n
 \nAbout the Speaker\n\nMarco Prunotto \n\nMarco is a Venture Partner at Me
 dicxi. Prior to joining Medicxi\, Marco was Global Head of Technology and 
 translational research at Roche Pharma I20 development where he was part o
 f the leadership team. He previously served as Head of Translational Resea
 rch at Galapagos NV. Prior to that he served in several roles within the d
 iscovery organisation of Roche pRED in Basel. He created and led the pheno
 typic drug discovery unit and led the nephrology discovery team. Marco rec
 eived a PhD in Biotechnology from the University of Turin and conducted po
 stdoctoral research at the University of Geneva. Marco also serves as seni
 or lecturer at the School of Pharmaceutical Sciences of the University of 
 Geneva.\n\nRegister\n\nBe part of the discussion with Medicxi\n\nReserve y
 our spot in-person. Space is limited!\n\nRegister here to receive the Zoom
  link\n\nConfirmation emails will be provided to registered participants a
  few days before the event.\n
DTSTART:20251104T150000Z
DTEND:20251104T160000Z
SUMMARY:Hybrid Event | D2R Investor Series  Transform your science into a n
 ew Biotech company - Investment Insights with Medicxi
URL:https://www.mcgill.ca/dna-to-rna/channels/event/hybrid-event-d2r-invest
 or-series-transform-your-science-new-biotech-company-investment-insights-3
 68366
END:VEVENT
END:VCALENDAR